287 related articles for article (PubMed ID: 34427680)
1. Assessment of the Diagnostic Efficiency of a Liquid Biopsy Assay for Early Detection of Gastric Cancer.
Izumi D; Zhu Z; Chen Y; Toden S; Huo X; Kanda M; Ishimoto T; Gu D; Tan M; Kodera Y; Baba H; Li W; Chen J; Wang X; Goel A
JAMA Netw Open; 2021 Aug; 4(8):e2121129. PubMed ID: 34427680
[TBL] [Abstract][Full Text] [Related]
2. A microRNA-based liquid biopsy signature for the early detection of esophageal squamous cell carcinoma: a retrospective, prospective and multicenter study.
Miyoshi J; Zhu Z; Luo A; Toden S; Zhou X; Izumi D; Kanda M; Takayama T; Parker IM; Wang M; Gao F; Zaidi AH; Baba H; Kodera Y; Cui Y; Wang X; Liu Z; Goel A
Mol Cancer; 2022 Feb; 21(1):44. PubMed ID: 35148754
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population.
So JBY; Kapoor R; Zhu F; Koh C; Zhou L; Zou R; Tang YC; Goo PCK; Rha SY; Chung HC; Yoong J; Yap CT; Rao J; Chia CK; Tsao S; Shabbir A; Lee J; Lam KP; Hartman M; Yong WP; Too HP; Yeoh KG
Gut; 2021 May; 70(5):829-837. PubMed ID: 33028667
[TBL] [Abstract][Full Text] [Related]
4. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.
Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L
JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic Patients.
Fehlmann T; Kahraman M; Ludwig N; Backes C; Galata V; Keller V; Geffers L; Mercaldo N; Hornung D; Weis T; Kayvanpour E; Abu-Halima M; Deuschle C; Schulte C; Suenkel U; von Thaler AK; Maetzler W; Herr C; Fähndrich S; Vogelmeier C; Guimaraes P; Hecksteden A; Meyer T; Metzger F; Diener C; Deutscher S; Abdul-Khaliq H; Stehle I; Haeusler S; Meiser A; Groesdonk HV; Volk T; Lenhof HP; Katus H; Balling R; Meder B; Kruger R; Huwer H; Bals R; Meese E; Keller A
JAMA Oncol; 2020 May; 6(5):714-723. PubMed ID: 32134442
[TBL] [Abstract][Full Text] [Related]
6. A liquid biopsy signature for predicting early recurrence in patients with gastric cancer.
Okuno K; Watanabe S; Roy S; Kanda M; Tokunaga M; Kodera Y; Kinugasa Y; Goel A
Br J Cancer; 2023 Apr; 128(6):1105-1116. PubMed ID: 36631634
[TBL] [Abstract][Full Text] [Related]
7. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer.
Roy S; Kanda M; Nomura S; Zhu Z; Toiyama Y; Taketomi A; Goldenring J; Baba H; Kodera Y; Goel A
Mol Cancer; 2022 Feb; 21(1):42. PubMed ID: 35139874
[TBL] [Abstract][Full Text] [Related]
9. OCaMIR-A Noninvasive, Diagnostic Signature for Early-Stage Ovarian Cancer: A Multi-cohort Retrospective and Prospective Study.
Kandimalla R; Wang W; Yu F; Zhou N; Gao F; Spillman M; Moukova L; Slaby O; Salhia B; Zhou S; Wang X; Goel A
Clin Cancer Res; 2021 Aug; 27(15):4277-4286. PubMed ID: 34035068
[TBL] [Abstract][Full Text] [Related]
10. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
11. Genomewide Expression Profiling Identifies a Novel miRNA-based Signature for the Detection of Peritoneal Metastasis in Patients With Gastric Cancer.
Shimura T; Toden S; Kandimalla R; Toiyama Y; Okugawa Y; Kanda M; Baba H; Kodera Y; Kusunoki M; Goel A
Ann Surg; 2021 Nov; 274(5):e425-e434. PubMed ID: 31663973
[TBL] [Abstract][Full Text] [Related]
12. A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients.
Guo X; Peng Y; Song Q; Wei J; Wang X; Ru Y; Xu S; Cheng X; Li X; Wu D; Chen L; Wei B; Lv X; Ji G
Gastroenterology; 2023 Aug; 165(2):402-413.e13. PubMed ID: 36894035
[TBL] [Abstract][Full Text] [Related]
13. A Liquid Biopsy Signature for the Detection of Patients With Early-Onset Colorectal Cancer.
Nakamura K; Hernández G; Sharma GG; Wada Y; Banwait JK; González N; Perea J; Balaguer F; Takamaru H; Saito Y; Toiyama Y; Kodera Y; Boland CR; Bujanda L; Quintero E; Goel A
Gastroenterology; 2022 Nov; 163(5):1242-1251.e2. PubMed ID: 35850198
[TBL] [Abstract][Full Text] [Related]
14. Polymer-Based Precipitation of Extracellular Vesicular miRNAs from Serum Improve Gastric Cancer miRNA Biomarker Performance.
Chung KY; Quek JM; Neo SH; Too HP
J Mol Diagn; 2020 May; 22(5):610-618. PubMed ID: 32151712
[TBL] [Abstract][Full Text] [Related]
15. A genomewide transcriptomic approach identifies a novel gene expression signature for the detection of lymph node metastasis in patients with early stage gastric cancer.
Izumi D; Gao F; Toden S; Sonohara F; Kanda M; Ishimoto T; Kodera Y; Wang X; Baba H; Goel A
EBioMedicine; 2019 Mar; 41():268-275. PubMed ID: 30772302
[TBL] [Abstract][Full Text] [Related]
16. Droplet digital PCR-based circulating microRNA detection serve as a promising diagnostic method for gastric cancer.
Zhao G; Jiang T; Liu Y; Huai G; Lan C; Li G; Jia G; Wang K; Yang M
BMC Cancer; 2018 Jun; 18(1):676. PubMed ID: 29929476
[TBL] [Abstract][Full Text] [Related]
17. Identification and external validation of a novel miRNA signature for lymph node metastasis prediction in submucosal-invasive gastric cancer patients.
Ma M; Lu S; Liu Y; Kong P; Long Z; Wan P; Zhang Y; Wang Y; Xu D
Cancer Med; 2019 Oct; 8(14):6315-6325. PubMed ID: 31486298
[TBL] [Abstract][Full Text] [Related]
18. The correlation of circulating pro-angiogenic miRNAs' expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer.
Peng W; Liu YN; Zhu SQ; Li WQ; Guo FC
Cancer Med; 2018 Aug; 7(8):3773-3791. PubMed ID: 30003708
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling.
Sudo K; Kato K; Matsuzaki J; Boku N; Abe S; Saito Y; Daiko H; Takizawa S; Aoki Y; Sakamoto H; Niida S; Takeshita F; Fukuda T; Ochiya T
JAMA Netw Open; 2019 May; 2(5):e194573. PubMed ID: 31125107
[TBL] [Abstract][Full Text] [Related]
20. A novel combination of serum microRNAs for the detection of early gastric cancer.
Abe S; Matsuzaki J; Sudo K; Oda I; Katai H; Kato K; Takizawa S; Sakamoto H; Takeshita F; Niida S; Saito Y; Ochiya T
Gastric Cancer; 2021 Jul; 24(4):835-843. PubMed ID: 33743111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
